Qol Holdings Co (TSE:3034) 3-Year Book Growth Rate : 7.00% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co 3-Year Book Growth Rate?

Qol Holdings Co's Book Value per Share for the quarter that ended in Dec. 2023 was 円1,384.55.

During the past 12 months, Qol Holdings Co's average Book Value per Share Growth Rate was 8.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 7.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was 6.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Qol Holdings Co was 136.00% per year. The lowest was 4.50% per year. And the median was 8.35% per year.

Competitive Comparison of Qol Holdings Co's 3-Year Book Growth Rate

For the Pharmaceutical Retailers subindustry, Qol Holdings Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qol Holdings Co's 3-Year Book Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Qol Holdings Co's 3-Year Book Growth Rate falls into.

Qol Holdings Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Qol Holdings Co (TSE:3034) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Qol Holdings Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qol Holdings Co (TSE:3034) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452

Website

https://www.qolhd.co.jp

Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines